Anti-atherogenic effect of statins: Role of nitric oxide, peroxynitrite and haem oxygenase-1

British Journal of Pharmacology

Volumn 156, Issue 8, 2009, Pages 1256-1266

  Heeba, G ^a,b   Moselhy, M E ^b   Hassan, M ^b   Khalifa, M ^b   Gryglewski, R ^c   Malinski, T ^a  

^a OHIO UNIVERSITY   (United States)

^b MINIA UNIVERSITY   (Egypt)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis and haem oxygenase; Endothelium; Lipid peroxidation; Nitric oxide; Peroxynitrite

Indexed keywords

ARGININE; ATORVASTATIN; CALCIUM IONOPHORE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; PROTOPORPHYRIN TIN; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; LIPID PEROXIDATION; NANOSENSOR; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

ANIMALS; AORTA; ARGININE; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEME OXYGENASE-1; HEMIN; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METALLOPORPHYRINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEROXYNITROUS ACID; PROTOPORPHYRINS; PYRROLES; RABBITS; SIMVASTATIN; TIME FACTORS;

EID: 68749092225     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00125.x     Document Type: Article

References (40)

1. Ahmed H, McLaughlin BE, Soong J, Marks GS, Brien JF, Nakatsu K (2005). The source of endogenous carbon monoxide formation in human placental chorionic villi. Cell Mol Biol (Noisy-le-grand) 51 : 447 451.
2. Baranano DE, Rao M, Ferris CD, Snyder SH (2002). Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99 : 16093 16098.
3. Beckman JSWDA, Crow JP (1996). Methods in Nitric Oxide. John Wiley and Sons, Ltd : New York.
4. Cyrus T, Tang LX, Rokach J, FitzGerald GA, Pratico D (2001). Lipid peroxidation and platelet activation in murine atherosclerosis. Circulation 104 : 1940 1945. (Pubitemid 32983238)
5. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI (1997). Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80 : 557 564. (Pubitemid 27137293)
6. Elbirt KK, Bonkovsky HL (1999). Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians 111 : 438 447.
7. Foresti R, Motterlini R (1999). The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 31 : 459 475.
8. Foresti R, Hoque M, Bains S, Green CJ, Motterlini R (2003). Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem J 372 : 381 390.
9. Foresti R, Bains S, Sulc F, Farmer PJ, Green CJ, Motterlini R (2006). The interaction of nitric oxide with distinct hemoglobins differentially amplifies endothelial heme uptake and heme oxygenase-1 expression. J Pharmacol Exp Ther 317 : 1125 1133.
10. Hsu M, Muchova L, Morioka I, Wong RJ, Schroder H, Stevenson DK (2006). Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343 : 738 744.
11. Ishikawa K (2003). Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. Curr Pharm Des 9 : 2489 2497.
12. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M et al. (2001a). Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104 : 1831 1836.
13. Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe H, Maruyama Y et al. (2001b). Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88 : 506 512.
14. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T et al. (2005). Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25 : 155 160.
15. Lanteri R, Acquaviva R, Di Giacomo C, Caltabiano R, Li Destri G, Vanella L et al. (2006). Heme oxygenase 1 expression in postischemic reperfusion liver damage: effect of L-arginine. Microsurgery 26 : 25 32.
16. Le Tourneau T, Van Belle E, Corseaux D, Vallet B, Lebuffe G, Dupuis B et al. (1999). Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling. J Am Coll Cardiol 33 : 876 882.
17. Lee TS, Chang CC, Zhu Y, Shyy JY (2004). Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110 : 1296 1302.
18. Liao JK (2005). Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96 : 24F 33F.
19. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G et al. (2006). Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis 187 : 26 30.
20. Maines MD (1988). Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2 : 2557 2568.
21. Malinski T, Taha Z (1992). Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358 : 676 678.
22. Motterlini R, Foresti R, Intaglietta M, Winslow RM (1996). NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270 : H107 H114.
23. Nakayama M, Takahashi K, Komaru T, Fukuchi M, Shioiri H, Sato K et al. (2001). Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21 : 1373 1377.
24. Novotny L, Vitek L (2003). Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 228 : 568 571.
25. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 : 351 358.
26. Patel RP, Diczfalusy U, Dzeletovic S, Wilson MT, Darley-Usmar VM (1996). Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J Lipid Res 37 : 2361 2371.
27. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, Wang H et al. (2002). Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99 : 4443 4448.
28. Polte T, Abate A, Dennery PA, Schroder H (2000). Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 20 : 1209 1215.
29. Radi R, Beckman JS, Bush KM, Freeman BA (1991). Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288 : 481 487.
30. Taille C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M et al. (2004). Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279 : 28681 28688.
31. Togane Y, Morita T, Suematsu M, Ishimura Y, Yamazaki JI, Katayama S (2000). Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 278 : H623 H632.
32. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF et al. (2005). Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289 : H701 H707.
33. Uchiyama T, Atsuta H, Utsugi T, Ohyama Y, Nakamura T, Nakai A et al. (2006). Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis 188 : 265 273.
34. Verd JC, Peris C, Alegret M, Diaz C, Hernandez G, Vazquez M et al. (1999). Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits. Br J Pharmacol 127 : 1479 1485.
35. Wang J, Lu S, Moenne-Loccoz P, Ortiz de Montellano PR (2003). Interaction of nitric oxide with human heme oxygenase-1. J Biol Chem 278 : 2341 2347.
36. Werner N, Nickenig G, Laufs U (2002). Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol 97 : 105 116.
37. Wierzbicki AS, Poston R, Ferro A (2003). The lipid and non-lipid effects of statins. Pharmacol Ther 99 : 95 112.
38. Wolin MS, Ahmed M, Gupte SA (2005). The sources of oxidative stress in the vessel wall. Kidney Int 67 : 1659 1661.
39. Yet SF, Pellacani A, Patterson C, Tan L, Folta SC, Foster L et al. (1997). Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 272 : 4295 4301.
40. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE et al. (2003). Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17 : 1759 1761.